{"transactions":[{"id":4614636,"issuer":{"id":5338,"kind":"organization","name":"ORTHOPEDIATRICS CORP","symbol":"KIDS"},"owners":[{"id":10099,"kind":"person","name":"Pelizzon David R","position":1,"cik":"0001719217","reported_name":"Pelizzon David R","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-09-10T20:21:14.000Z","date":"2026-09-10","kind":"sale","planned":false,"acquired":false,"shares":302369,"price":21.01,"value":6352772.69,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was undertaken by Squadron Capital LLC to provide additional capital for its other portfolio businesses."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.00 to $21.69, inclusive. The reporting person undertakes to\nprovide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price\nwithin the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are held by Squadron Capital LLC (\"Squadron\"). As the President and a member of the Managing Committee of Squadron, the reporting person may be deemed to be the beneficial owner of these shares. The reporting person expressly disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein. The inclusion of these shares in this report shall not be deemed to be an admission of beneficial ownership for purposes of Section 16 or for any other purpose."}],"balance_after":6201764,"source":{"system":"sec-edgar","filing":"0001425450-26-000087","document":"wk-form4_1789071671.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1719217/000142545026000087/wk-form4_1789071671.xml","form_type":"4"}},{"id":4534,"issuer":{"id":5338,"kind":"organization","name":"ORTHOPEDIATRICS CORP","symbol":"KIDS"},"owners":[{"id":10099,"kind":"person","name":"Pelizzon David R","position":1,"cik":"0001719217","reported_name":"Pelizzon David R","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-09-04T20:26:39.000Z","date":"2026-09-02","kind":"sale","planned":false,"acquired":false,"shares":22500,"price":23.35,"value":525375.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was undertaken by Squadron Capital LLC to provide additional capital for its other portfolio businesses."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.01 to $23.74, inclusive. The reporting person undertakes to\nprovide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price\nwithin the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are held by Squadron Capital LLC (\"Squadron\"). As the President and a member of the Managing Committee of Squadron, the reporting person may be deemed to be the beneficial owner of these shares. The reporting person expressly disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein. The inclusion of these shares in this report shall not be deemed to be an admission of beneficial ownership for purposes of Section 16 or for any other purpose."}],"balance_after":6504133,"source":{"system":"sec-edgar","filing":"0001425450-26-000085","document":"wk-form4_1788553597.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1719217/000142545026000085/wk-form4_1788553597.xml","form_type":"4"}},{"id":671006,"issuer":{"id":5338,"kind":"organization","name":"ORTHOPEDIATRICS CORP","symbol":"KIDS"},"owners":[{"id":10099,"kind":"person","name":"Pelizzon David R","position":1,"cik":"0001719217","reported_name":"Pelizzon David R","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-09-01T21:13:51.000Z","date":"2026-09-01","kind":"sale","planned":false,"acquired":false,"shares":10131,"price":23.1,"value":234026.1,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was undertaken by Squadron Capital LLC to provide additional capital for its other portfolio businesses."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.00 to $23.58, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are held by Squadron Capital LLC (\"Squadron\"). As the President and a member of the Managing Committee of Squadron, the reporting person may be deemed to be the beneficial owner of these shares. The reporting person expressly disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein. The inclusion of these shares in this report shall not be deemed to be an admission of beneficial ownership for purposes of Section 16 or for any other purpose."}],"balance_after":6526633,"source":{"system":"sec-edgar","filing":"0001425450-26-000083","document":"wk-form4_1788297228.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1425450/000142545026000083/wk-form4_1788297228.xml","form_type":"4"}},{"id":671005,"issuer":{"id":5338,"kind":"organization","name":"ORTHOPEDIATRICS CORP","symbol":"KIDS"},"owners":[{"id":10099,"kind":"person","name":"Pelizzon David R","position":1,"cik":"0001719217","reported_name":"Pelizzon David R","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-09-01T21:13:51.000Z","date":"2026-08-28","kind":"sale","planned":false,"acquired":false,"shares":326700,"price":23.04,"value":7527168.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was undertaken by Squadron Capital LLC to provide additional capital for its other portfolio businesses."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.00 to $23.82, inclusive. The reporting person undertakes to\nprovide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price\nwithin the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are held by Squadron Capital LLC (\"Squadron\"). As the President and a member of the Managing Committee of Squadron, the reporting person may be deemed to be the beneficial owner of these shares. The reporting person expressly disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein. The inclusion of these shares in this report shall not be deemed to be an admission of beneficial ownership for purposes of Section 16 or for any other purpose."}],"balance_after":6536764,"source":{"system":"sec-edgar","filing":"0001425450-26-000083","document":"wk-form4_1788297228.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425450/000142545026000083/wk-form4_1788297228.xml","form_type":"4"}},{"id":674890,"issuer":{"id":5338,"kind":"organization","name":"ORTHOPEDIATRICS CORP","symbol":"KIDS"},"owners":[{"id":10099,"kind":"person","name":"Pelizzon David R","position":1,"cik":"0001719217","reported_name":"Pelizzon David R","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-08-26T22:17:35.000Z","date":"2026-08-26","kind":"sale","planned":false,"acquired":false,"shares":18000,"price":24.28,"value":437040.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was undertaken by Squadron Capital LLC to provide additional capital for its other portfolio businesses."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.13 to $24.36, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote"},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are held by Squadron Capital LLC (\"Squadron\"). As the President and a member of the Managing Committee of Squadron, the reporting person may be deemed to be the beneficial owner of these shares. The reporting person expressly disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein. The inclusion of these shares in this report shall not be deemed to be an admission of beneficial ownership for purposes of Section 16 or for any other purpose."}],"balance_after":6863464,"source":{"system":"sec-edgar","filing":"0001425450-26-000081","document":"wk-form4_1787782652.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1425450/000142545026000081/wk-form4_1787782652.xml","form_type":"4"}},{"id":674889,"issuer":{"id":5338,"kind":"organization","name":"ORTHOPEDIATRICS CORP","symbol":"KIDS"},"owners":[{"id":10099,"kind":"person","name":"Pelizzon David R","position":1,"cik":"0001719217","reported_name":"Pelizzon David R","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-08-26T22:17:35.000Z","date":"2026-08-25","kind":"sale","planned":false,"acquired":false,"shares":16300,"price":24.74,"value":403262.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was undertaken by Squadron Capital LLC to provide additional capital for its other portfolio businesses."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.53 to $24.88, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are held by Squadron Capital LLC (\"Squadron\"). As the President and a member of the Managing Committee of Squadron, the reporting person may be deemed to be the beneficial owner of these shares. The reporting person expressly disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein. The inclusion of these shares in this report shall not be deemed to be an admission of beneficial ownership for purposes of Section 16 or for any other purpose."}],"balance_after":6881464,"source":{"system":"sec-edgar","filing":"0001425450-26-000081","document":"wk-form4_1787782652.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1425450/000142545026000081/wk-form4_1787782652.xml","form_type":"4"}},{"id":674888,"issuer":{"id":5338,"kind":"organization","name":"ORTHOPEDIATRICS CORP","symbol":"KIDS"},"owners":[{"id":10099,"kind":"person","name":"Pelizzon David R","position":1,"cik":"0001719217","reported_name":"Pelizzon David R","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-08-26T22:17:35.000Z","date":"2026-08-24","kind":"sale","planned":false,"acquired":false,"shares":4000,"price":25.75,"value":103000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was undertaken by Squadron Capital LLC to provide additional capital for its other portfolio businesses."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.50 to $25.82,\ninclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission,\nupon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are held by Squadron Capital LLC (\"Squadron\"). As the President and a member of the Managing Committee of Squadron, the reporting person may be deemed to be the beneficial owner of these shares. The reporting person expressly disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein. The inclusion of these shares in this report shall not be deemed to be an admission of beneficial ownership for purposes of Section 16 or for any other purpose."}],"balance_after":6897764,"source":{"system":"sec-edgar","filing":"0001425450-26-000081","document":"wk-form4_1787782652.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425450/000142545026000081/wk-form4_1787782652.xml","form_type":"4"}},{"id":739391,"issuer":{"id":4720,"kind":"organization","name":"Alphatec Holdings, Inc.","symbol":"ATEC"},"owners":[{"id":10099,"kind":"person","name":"Pelizzon David R","position":1,"cik":"0001719217","reported_name":"Pelizzon David R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-12T21:30:13.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":32012,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On June 10, 2026, issuer granted to the reporting person 32,012 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On June 10, 2026, issuer granted to the reporting person 32,012 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On June 10, 2026, issuer granted to the reporting person 32,012 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365."}],"balance_after":378839,"source":{"system":"sec-edgar","filing":"0001719217-26-000002","document":"form4-06122026_050606.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1350653/000171921726000002/form4-06122026_050606.xml","form_type":"4"}},{"id":743009,"issuer":{"id":5338,"kind":"organization","name":"ORTHOPEDIATRICS CORP","symbol":"KIDS"},"owners":[{"id":10099,"kind":"person","name":"Pelizzon David R","position":1,"cik":"0001719217","reported_name":"Pelizzon David R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-10T13:54:21.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":11436,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes restricted stock awards totaling 17,959 shares."}],"balance_after":44384,"source":{"system":"sec-edgar","filing":"0001425450-26-000061","document":"wk-form4_1781099658.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425450/000142545026000061/wk-form4_1781099658.xml","form_type":"4"}},{"id":962915,"issuer":{"id":4720,"kind":"organization","name":"Alphatec Holdings, Inc.","symbol":"ATEC"},"owners":[{"id":10099,"kind":"person","name":"Pelizzon David R","position":1,"cik":"0001719217","reported_name":"Pelizzon David R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-19T00:28:40.000Z","date":"2025-12-16","kind":"sale","planned":false,"acquired":false,"shares":250000,"price":19.66,"value":4915000.0,"ownership":{"direct":false,"nature":"By Squadron Capital LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.33 to $19.99, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by Squadron Capital LLC (\"Squadron\"). As one of two members of the Managing Committee of Squadron, the reporting person may be deemed to be the beneficial owner of these shares. The reporting person expressly disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein. The inclusion of these shares in this report shall not be deemed to be an admission of beneficial ownership for purposes of Section 16 or for any other purpose."}],"balance_after":10395045,"source":{"system":"sec-edgar","filing":"0001719217-25-000009","document":"form4-12192025_121237.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1350653/000171921725000009/form4-12192025_121237.xml","form_type":"4"}},{"id":974192,"issuer":{"id":4720,"kind":"organization","name":"Alphatec Holdings, Inc.","symbol":"ATEC"},"owners":[{"id":10099,"kind":"person","name":"Pelizzon David R","position":1,"cik":"0001719217","reported_name":"Pelizzon David R","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-12-11T00:00:13.000Z","date":"2025-12-09","kind":"sale","planned":false,"acquired":false,"shares":28834,"price":21.03,"value":606379.02,"ownership":{"direct":false,"nature":"By Squadron Capital LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.91 to $21.11, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by Squadron Capital LLC (\"Squadron\"). As one of two members of the Managing Committee of Squadron, the reporting person may be deemed to be the beneficial owner of these shares. The reporting person expressly disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein. The inclusion of these shares in this report shall not be deemed to be an admission of beneficial ownership for purposes of Section 16 or for any other purpose."}],"balance_after":10645045,"source":{"system":"sec-edgar","filing":"0001719217-25-000007","document":"form4-12102025_071210.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1350653/000171921725000007/form4-12102025_071210.xml","form_type":"4"}},{"id":974191,"issuer":{"id":4720,"kind":"organization","name":"Alphatec Holdings, Inc.","symbol":"ATEC"},"owners":[{"id":10099,"kind":"person","name":"Pelizzon David R","position":1,"cik":"0001719217","reported_name":"Pelizzon David R","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-12-11T00:00:13.000Z","date":"2025-12-08","kind":"sale","planned":false,"acquired":false,"shares":221166,"price":21.2,"value":4688719.2,"ownership":{"direct":false,"nature":"By Squadron Capital LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.00 to $21.42, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by Squadron Capital LLC (\"Squadron\"). As one of two members of the Managing Committee of Squadron, the reporting person may be deemed to be the beneficial owner of these shares. The reporting person expressly disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein. The inclusion of these shares in this report shall not be deemed to be an admission of beneficial ownership for purposes of Section 16 or for any other purpose."}],"balance_after":10673879,"source":{"system":"sec-edgar","filing":"0001719217-25-000007","document":"form4-12102025_071210.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1350653/000171921725000007/form4-12102025_071210.xml","form_type":"4"}},{"id":988462,"issuer":{"id":4720,"kind":"organization","name":"Alphatec Holdings, Inc.","symbol":"ATEC"},"owners":[{"id":10099,"kind":"person","name":"Pelizzon David R","position":1,"cik":"0001719217","reported_name":"Pelizzon David R","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-11-26T00:00:07.000Z","date":"2025-11-24","kind":"sale","planned":false,"acquired":false,"shares":250000,"price":20.62,"value":5155000.0,"ownership":{"direct":false,"nature":"By Squadron Capital LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.34 to $20.79, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by Squadron Capital LLC (\"Squadron\"). As one of two members of the Managing Committee of Squadron, the reporting person may be deemed to be the beneficial owner of these shares. The reporting person expressly disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein. The inclusion of these shares in this report shall not be deemed to be an admission of beneficial ownership for purposes of Section 16 or for any other purpose."}],"balance_after":10895045,"source":{"system":"sec-edgar","filing":"0001719217-25-000005","document":"form4-11252025_071103.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1350653/000171921725000005/form4-11252025_071103.xml","form_type":"4"}},{"id":998728,"issuer":{"id":4720,"kind":"organization","name":"Alphatec Holdings, Inc.","symbol":"ATEC"},"owners":[{"id":10099,"kind":"person","name":"Pelizzon David R","position":1,"cik":"0001719217","reported_name":"Pelizzon David R","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-11-14T21:36:14.000Z","date":"2025-11-12","kind":"sale","planned":false,"acquired":false,"shares":250000,"price":20.8,"value":5200000.0,"ownership":{"direct":false,"nature":"By Squadron Capital LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.67 to $21.07, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by Squadron Capital LLC (\"Squadron\"). As one of two members of the Managing Committee of Squadron, the reporting person may be deemed to be the beneficial owner of these shares. The reporting person expressly disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein. The inclusion of these shares in this report shall not be deemed to be an admission of beneficial ownership for purposes of Section 16 or for any other purpose."}],"balance_after":11145045,"source":{"system":"sec-edgar","filing":"0001719217-25-000003","document":"form4-11142025_091108.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1350653/000171921725000003/form4-11142025_091108.xml","form_type":"4"}},{"id":1111197,"issuer":{"id":4720,"kind":"organization","name":"Alphatec Holdings, Inc.","symbol":"ATEC"},"owners":[{"id":10099,"kind":"person","name":"Pelizzon David R","position":1,"cik":"0001719217","reported_name":"Pelizzon David R","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-06-13T21:30:10.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":15131,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On June 11, 2025, issuer granted to the reporting person 15,131 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On June 11, 2025, issuer granted to the reporting person 15,131 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On June 11, 2025, issuer granted to the reporting person 15,131 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365."}],"balance_after":346827,"source":{"system":"sec-edgar","filing":"0001415889-25-017264","document":"form4-06132025_050607.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1350653/000141588925017264/form4-06132025_050607.xml","form_type":"4"}},{"id":1131763,"issuer":{"id":5338,"kind":"organization","name":"ORTHOPEDIATRICS CORP","symbol":"KIDS"},"owners":[{"id":10099,"kind":"person","name":"Pelizzon David R","position":1,"cik":"0001719217","reported_name":"Pelizzon David R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-28T12:52:19.000Z","date":"2025-05-23","kind":"grant","planned":false,"acquired":true,"shares":8401,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes restricted stock awards totaling 10,900 shares."}],"balance_after":32948,"source":{"system":"sec-edgar","filing":"0001425450-25-000065","document":"wk-form4_1748436733.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425450/000142545025000065/wk-form4_1748436733.xml","form_type":"4"}},{"id":1423112,"issuer":{"id":4720,"kind":"organization","name":"Alphatec Holdings, Inc.","symbol":"ATEC"},"owners":[{"id":10099,"kind":"person","name":"Pelizzon David R","position":1,"cik":"0001719217","reported_name":"Pelizzon David R","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-08-26T20:27:25.000Z","date":"2024-08-23","kind":"purchase","planned":false,"acquired":true,"shares":16978,"price":5.89,"value":100000.42,"ownership":{"direct":true},"balance_after":331696,"source":{"system":"sec-edgar","filing":"0001415889-24-022226","document":"form4-08262024_080822.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1350653/000141588924022226/form4-08262024_080822.xml","form_type":"4"}},{"id":1423111,"issuer":{"id":4720,"kind":"organization","name":"Alphatec Holdings, Inc.","symbol":"ATEC"},"owners":[{"id":10099,"kind":"person","name":"Pelizzon David R","position":1,"cik":"0001719217","reported_name":"Pelizzon David R","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-08-26T20:27:25.000Z","date":"2024-08-22","kind":"purchase","planned":false,"acquired":true,"shares":8818,"price":5.67,"value":49998.06,"ownership":{"direct":true},"balance_after":314718,"source":{"system":"sec-edgar","filing":"0001415889-24-022226","document":"form4-08262024_080822.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1350653/000141588924022226/form4-08262024_080822.xml","form_type":"4"}},{"id":1478662,"issuer":{"id":4720,"kind":"organization","name":"Alphatec Holdings, Inc.","symbol":"ATEC"},"owners":[{"id":10099,"kind":"person","name":"Pelizzon David R","position":1,"cik":"0001719217","reported_name":"Pelizzon David R","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-06-14T20:30:18.000Z","date":"2024-06-12","kind":"grant","planned":false,"acquired":true,"shares":16747,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On June 12, 2024, issuer granted to the reporting person 16,747 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On June 12, 2024, issuer granted to the reporting person 16,747 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On June 12, 2024, issuer granted to the reporting person 16,747 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365."}],"balance_after":305900,"source":{"system":"sec-edgar","filing":"0001415889-24-016930","document":"form4-06142024_040614.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1350653/000141588924016930/form4-06142024_040614.xml","form_type":"4"}},{"id":1497745,"issuer":{"id":5338,"kind":"organization","name":"ORTHOPEDIATRICS CORP","symbol":"KIDS"},"owners":[{"id":10099,"kind":"person","name":"Pelizzon David R","position":1,"cik":"0001719217","reported_name":"Pelizzon David R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-30T20:41:32.000Z","date":"2024-05-28","kind":"grant","planned":false,"acquired":true,"shares":2766,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes restricted stock awards totaling 4,640 shares."}],"balance_after":24547,"source":{"system":"sec-edgar","filing":"0001425450-24-000047","document":"wk-form4_1717101683.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425450/000142545024000047/wk-form4_1717101683.xml","form_type":"4"}},{"id":1847592,"issuer":{"id":4720,"kind":"organization","name":"Alphatec Holdings, Inc.","symbol":"ATEC"},"owners":[{"id":10099,"kind":"person","name":"Pelizzon David R","position":1,"cik":"0001719217","reported_name":"Pelizzon David R","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-06-22T00:05:16.000Z","date":"2023-06-20","kind":"grant","planned":false,"acquired":true,"shares":9908,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On June 20, 2023, issuer granted to the reporting person 9,908 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On June 20, 2023, issuer granted to the reporting person 9,908 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On June 20, 2023, issuer granted to the reporting person 9,908 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365."}],"balance_after":289153,"source":{"system":"sec-edgar","filing":"0001415889-23-010124","document":"form4-06222023_120610.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1350653/000141588923010124/form4-06222023_120610.xml","form_type":"4"}},{"id":1854189,"issuer":{"id":5338,"kind":"organization","name":"ORTHOPEDIATRICS CORP","symbol":"KIDS"},"owners":[{"id":10099,"kind":"person","name":"Pelizzon David R","position":1,"cik":"0001719217","reported_name":"Pelizzon David R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-15T19:32:20.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":1965,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes restricted stock awards totaling 3,560 shares."}],"balance_after":21781,"source":{"system":"sec-edgar","filing":"0001425450-23-000082","document":"wk-form4_1686857532.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425450/000142545023000082/wk-form4_1686857532.xml","form_type":"4"}},{"id":1951864,"issuer":{"id":4720,"kind":"organization","name":"Alphatec Holdings, Inc.","symbol":"ATEC"},"owners":[{"id":10099,"kind":"person","name":"Pelizzon David R","position":1,"cik":"0001719217","reported_name":"Pelizzon David R","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-03-15T20:45:42.000Z","date":"2023-03-13","kind":"purchase","acquired":true,"shares":3100,"price":15.24,"value":47244.0,"ownership":{"direct":true},"balance_after":279245,"source":{"system":"sec-edgar","filing":"0000899243-23-008574","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1350653/000089924323008574/doc4.xml","form_type":"4"}},{"id":2032411,"issuer":{"id":4720,"kind":"organization","name":"Alphatec Holdings, Inc.","symbol":"ATEC"},"owners":[{"id":10099,"kind":"person","name":"Pelizzon David R","position":1,"cik":"0001719217","reported_name":"Pelizzon David R","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-02-03T22:56:35.000Z","date":"2022-09-06","kind":"gift","acquired":false,"shares":31250,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":276145,"source":{"system":"sec-edgar","filing":"0000899243-23-003915","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1350653/000089924323003915/doc5.xml","form_type":"5"}},{"id":2032713,"issuer":{"id":5338,"kind":"organization","name":"ORTHOPEDIATRICS CORP","symbol":"KIDS"},"owners":[{"id":10099,"kind":"person","name":"Pelizzon David R","position":1,"cik":"0001719217","reported_name":"Pelizzon David R","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-02-03T22:55:46.000Z","date":"2022-09-02","kind":"gift","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":19816,"source":{"system":"sec-edgar","filing":"0000899243-23-003913","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425450/000089924323003913/doc5.xml","form_type":"5"}},{"id":2152638,"issuer":{"id":5338,"kind":"organization","name":"ORTHOPEDIATRICS CORP","symbol":"KIDS"},"owners":[{"id":10099,"kind":"person","name":"Pelizzon David R","position":1,"cik":"0001719217","reported_name":"Pelizzon David R","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants (right to buy)","published_at":"2022-09-22T11:31:03.000Z","date":"2022-09-20","kind":"other","acquired":true,"shares":1525000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Squadron beneficially owns shares of the Issuer's common stock with a market value in excess of the notification threshold of the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the \"HSR Act\"). The warrants could not be exercised until the expiration of all applicable HSR Act waiting periods or the exercise otherwise becomes exempt from the notification requirements thereunder. On September 19, 2022, the waiting period under the HSR Act expired. Once the warrants became exercisable, Squadron Capital LLC was obligated to exercise them within five (5) business days."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Squadron beneficially owns shares of the Issuer's common stock with a market value in excess of the notification threshold of the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the \"HSR Act\"). The warrants could not be exercised until the expiration of all applicable HSR Act waiting periods or the exercise otherwise becomes exempt from the notification requirements thereunder. On September 19, 2022, the waiting period under the HSR Act expired. Once the warrants became exercisable, Squadron Capital LLC was obligated to exercise them within five (5) business days."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are held directly by Squadron Capital LLC (\"Squadron\"). As the President and a member of the Managing Committee of Squadron, the reporting person may be deemed to be the beneficial owner of these securities. The reporting person expressly disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein. The inclusion of these securities in this report shall not be deemed to be an admission of beneficial ownership for purposes of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"exercise_price":0.0003,"underlying":"Common Stock","underlying_shares":1525000},"source":{"system":"sec-edgar","filing":"0000899243-22-031659","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1425450/000089924322031659/doc4.xml","form_type":"4"}},{"id":2152637,"issuer":{"id":5338,"kind":"organization","name":"ORTHOPEDIATRICS CORP","symbol":"KIDS"},"owners":[{"id":10099,"kind":"person","name":"Pelizzon David R","position":1,"cik":"0001719217","reported_name":"Pelizzon David R","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-09-22T11:31:03.000Z","date":"2022-09-20","kind":"other","acquired":true,"shares":1525000,"price":0.0003,"value":457.5,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are held directly by Squadron Capital LLC (\"Squadron\"). As the President and a member of the Managing Committee of Squadron, the reporting person may be deemed to be the beneficial owner of these securities. The reporting person expressly disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein. The inclusion of these securities in this report shall not be deemed to be an admission of beneficial ownership for purposes of Section 16 or for any other purpose."}],"balance_after":6901764,"source":{"system":"sec-edgar","filing":"0000899243-22-031659","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425450/000089924322031659/doc4.xml","form_type":"4"}},{"id":2185525,"issuer":{"id":5338,"kind":"organization","name":"ORTHOPEDIATRICS CORP","symbol":"KIDS"},"owners":[{"id":10099,"kind":"person","name":"Pelizzon David R","position":1,"cik":"0001719217","reported_name":"Pelizzon David R","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants (right to buy)","published_at":"2022-08-15T21:38:31.000Z","date":"2022-08-11","kind":"purchase","acquired":true,"shares":1525000,"price":54.9998,"value":83874695.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Squadron Capital LLC (\"Squadron\") beneficially owns shares of the Issuer's common stock with a market value in excess of the notification threshold of the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the \"HSR Act\"). The warrants may not be exercised until the expiration of all applicable HSR Act waiting periods or the exercise otherwise becomes exempt from the notification requirements thereunder. Once the warrants become exercisable, Squadron is obligated to exercise them within five (5) business days."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Squadron Capital LLC (\"Squadron\") beneficially owns shares of the Issuer's common stock with a market value in excess of the notification threshold of the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the \"HSR Act\"). The warrants may not be exercised until the expiration of all applicable HSR Act waiting periods or the exercise otherwise becomes exempt from the notification requirements thereunder. Once the warrants become exercisable, Squadron is obligated to exercise them within five (5) business days."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Squadron. As the President and a member of the Managing Committee of Squadron, the reporting person may be deemed to be the beneficial owner of these securities. The reporting person expressly disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein. The inclusion of these securities in this report shall not be deemed to be an admission of beneficial ownership for purposes of Section 16 or for any other purpose."}],"balance_after":1525000,"derivative":{"exercise_price":0.0003,"underlying":"Common Stock","underlying_shares":1525000},"source":{"system":"sec-edgar","filing":"0000899243-22-028657","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425450/000089924322028657/doc4.xml","form_type":"4"}},{"id":2227120,"issuer":{"id":4720,"kind":"organization","name":"Alphatec Holdings, Inc.","symbol":"ATEC"},"owners":[{"id":10099,"kind":"person","name":"Pelizzon David R","position":1,"cik":"0001719217","reported_name":"Pelizzon David R","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-06-17T19:30:16.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":18546,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On June 15, 2022, issuer granted to the reporting person 18,546 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On June 15, 2022, issuer granted to the reporting person 18,546 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365."},{"field":"shares","element":"transactionShares","label":"F1","text":"On June 15, 2022, issuer granted to the reporting person 18,546 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On June 15, 2022, issuer granted to the reporting person 18,546 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On June 15, 2022, issuer granted to the reporting person 18,546 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365."}],"balance_after":307395,"source":{"system":"sec-edgar","filing":"0001179110-22-003360","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1350653/000117911022003360/edgar.xml","form_type":"4"}},{"id":2244400,"issuer":{"id":5338,"kind":"organization","name":"ORTHOPEDIATRICS CORP","symbol":"KIDS"},"owners":[{"id":10099,"kind":"person","name":"Pelizzon David R","position":1,"cik":"0001719217","reported_name":"Pelizzon David R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-03T12:17:20.000Z","date":"2022-06-01","kind":"grant","acquired":true,"shares":1691,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes restricted stock awards totaling 3,092 shares."}],"balance_after":24816,"source":{"system":"sec-edgar","filing":"0001425450-22-000070","document":"wf-form4_165425862720437.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425450/000142545022000070/wf-form4_165425862720437.xml","form_type":"4"}},{"id":2512462,"issuer":{"id":4720,"kind":"organization","name":"Alphatec Holdings, Inc.","symbol":"ATEC"},"owners":[{"id":10099,"kind":"person","name":"Pelizzon David R","position":1,"cik":"0001719217","reported_name":"Pelizzon David R","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-11-16T00:02:35.000Z","date":"2021-11-11","kind":"purchase","acquired":true,"shares":4366,"price":11.41,"value":49816.06,"ownership":{"direct":true},"balance_after":288849,"source":{"system":"sec-edgar","filing":"0001179110-21-010133","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1350653/000117911021010133/edgar.xml","form_type":"4"}},{"id":2514843,"issuer":{"id":5338,"kind":"organization","name":"ORTHOPEDIATRICS CORP","symbol":"KIDS"},"owners":[{"id":10099,"kind":"person","name":"Pelizzon David R","position":1,"cik":"0001719217","reported_name":"Pelizzon David R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-12T20:29:38.000Z","date":"2021-11-11","kind":"purchase","acquired":true,"shares":825,"price":66.48,"value":54846.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares purchased by Mr. Pelizzon in the open market."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock awards totaling 2,801 shares."}],"balance_after":23125,"source":{"system":"sec-edgar","filing":"0001425450-21-000155","document":"wf-form4_163674896073977.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425450/000142545021000155/wf-form4_163674896073977.xml","form_type":"4"}},{"id":2517494,"issuer":{"id":4720,"kind":"organization","name":"Alphatec Holdings, Inc.","symbol":"ATEC"},"owners":[{"id":10099,"kind":"person","name":"Pelizzon David R","position":1,"cik":"0001719217","reported_name":"Pelizzon David R","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-11-10T19:38:49.000Z","date":"2021-11-08","kind":"purchase","acquired":true,"shares":5425,"price":13,"value":70525.0,"ownership":{"direct":true},"balance_after":284483,"source":{"system":"sec-edgar","filing":"0001179110-21-010028","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1350653/000117911021010028/edgar.xml","form_type":"4"}},{"id":2660369,"issuer":{"id":4720,"kind":"organization","name":"Alphatec Holdings, Inc.","symbol":"ATEC"},"owners":[{"id":10099,"kind":"person","name":"Pelizzon David R","position":1,"cik":"0001719217","reported_name":"Pelizzon David R","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-06-21T22:29:48.000Z","date":"2021-06-16","kind":"grant","acquired":true,"shares":10221,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 16, 2021, the Issuer granted to the reporting person 10,221 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vest on the 12 month anniversary of the grant date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On June 16, 2021, the Issuer granted to the reporting person 10,221 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vest on the 12 month anniversary of the grant date."}],"balance_after":279058,"source":{"system":"sec-edgar","filing":"0000899243-21-025076","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1350653/000089924321025076/doc4.xml","form_type":"4"}},{"id":2680798,"issuer":{"id":5338,"kind":"organization","name":"ORTHOPEDIATRICS CORP","symbol":"KIDS"},"owners":[{"id":10099,"kind":"person","name":"Pelizzon David R","position":1,"cik":"0001719217","reported_name":"Pelizzon David R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-04T18:30:21.000Z","date":"2021-06-02","kind":"grant","acquired":true,"shares":1400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes restricted stock awards totaling 2,801 shares."}],"balance_after":22300,"source":{"system":"sec-edgar","filing":"0001425450-21-000097","document":"wf-form4_162283140859682.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425450/000142545021000097/wf-form4_162283140859682.xml","form_type":"4"}},{"id":2715980,"issuer":{"id":4720,"kind":"organization","name":"Alphatec Holdings, Inc.","symbol":"ATEC"},"owners":[{"id":10099,"kind":"person","name":"Pelizzon David R","position":1,"cik":"0001719217","reported_name":"Pelizzon David R","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-05-12T21:25:47.000Z","date":"2021-05-10","kind":"purchase","acquired":true,"shares":120000,"price":15.25,"value":1830000.0,"ownership":{"direct":true},"balance_after":268837,"source":{"system":"sec-edgar","filing":"0000899243-21-019280","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1350653/000089924321019280/doc4.xml","form_type":"4"}},{"id":2781901,"issuer":{"id":5338,"kind":"organization","name":"ORTHOPEDIATRICS CORP","symbol":"KIDS"},"owners":[{"id":10099,"kind":"person","name":"Pelizzon David R","position":1,"cik":"0001719217","reported_name":"Pelizzon David R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-17T14:00:02.000Z","date":"2021-03-15","kind":"purchase","acquired":true,"shares":3700,"price":46.5,"value":172050.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares purchased by Mr. Pelizzon in the open market."}],"balance_after":20900,"source":{"system":"sec-edgar","filing":"0001425450-21-000053","document":"wf-form4_161598958771882.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425450/000142545021000053/wf-form4_161598958771882.xml","form_type":"4"}},{"id":2796478,"issuer":{"id":4720,"kind":"organization","name":"Alphatec Holdings, Inc.","symbol":"ATEC"},"owners":[{"id":10099,"kind":"person","name":"Pelizzon David R","position":1,"cik":"0001719217","reported_name":"Pelizzon David R","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-03-10T21:48:32.000Z","date":"2021-03-08","kind":"purchase","acquired":true,"shares":695,"price":15.93,"value":11071.35,"ownership":{"direct":true},"balance_after":148837,"source":{"system":"sec-edgar","filing":"0000899243-21-010986","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1350653/000089924321010986/doc4.xml","form_type":"4"}},{"id":2796477,"issuer":{"id":4720,"kind":"organization","name":"Alphatec Holdings, Inc.","symbol":"ATEC"},"owners":[{"id":10099,"kind":"person","name":"Pelizzon David R","position":1,"cik":"0001719217","reported_name":"Pelizzon David R","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-03-10T21:48:32.000Z","date":"2021-03-08","kind":"purchase","acquired":true,"shares":4003,"price":15.5,"value":62046.5,"ownership":{"direct":true},"balance_after":148142,"source":{"system":"sec-edgar","filing":"0000899243-21-010986","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1350653/000089924321010986/doc4.xml","form_type":"4"}},{"id":2812032,"issuer":{"id":4720,"kind":"organization","name":"Alphatec Holdings, Inc.","symbol":"ATEC"},"owners":[{"id":10099,"kind":"person","name":"Pelizzon David R","position":1,"cik":"0001719217","reported_name":"Pelizzon David R","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-03-03T22:10:36.000Z","date":"2021-03-01","kind":"purchase","acquired":true,"shares":8100810,"price":11.11,"value":89999999.1,"ownership":{"direct":false,"nature":"By Squadron Capital LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are held by Squadron Capital LLC (\"Squadron\"). As one of two members of the Managing Committee of Squadron, the reporting person may be deemed to be the beneficial owner of these shares. The reporting person expressly disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein. The inclusion of these shares in this report shall not be deemed to be an admission of beneficial ownership for purposes of Section 16 or for any other purpose."}],"balance_after":11395045,"source":{"system":"sec-edgar","filing":"0000899243-21-009425","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1350653/000089924321009425/doc4.xml","form_type":"4"}},{"id":2894899,"issuer":{"id":4720,"kind":"organization","name":"Alphatec Holdings, Inc.","symbol":"ATEC"},"owners":[{"id":10099,"kind":"person","name":"Pelizzon David R","position":1,"cik":"0001719217","reported_name":"Pelizzon David R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-26T19:15:21.000Z","date":"2020-10-16","kind":"purchase","acquired":true,"shares":857143,"price":8.75,"value":7500001.25,"ownership":{"direct":false,"nature":"By Squadron Capital LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are held by Squadron Capital LLC (\"Squadron\"). As the President and a member of the Managing Committee of Squadron, the reporting person may be deemed to be the beneficial owner of these shares. The reporting person expressly disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein. The inclusion of these shares in this report shall not be deemed to be an admission of beneficial ownership for purposes of Section 16 or for any other purpose."}],"balance_after":3294235,"source":{"system":"sec-edgar","filing":"0001179110-21-000832","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1350653/000117911021000832/edgar.xml","form_type":"5"}},{"id":2934356,"issuer":{"id":4720,"kind":"organization","name":"Alphatec Holdings, Inc.","symbol":"ATEC"},"owners":[{"id":10099,"kind":"person","name":"Pelizzon David R","position":1,"cik":"0001719217","reported_name":"Pelizzon David R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-22T23:45:54.000Z","date":"2020-12-18","kind":"grant","acquired":true,"shares":1350135,"price":11.11,"value":14999999.85,"ownership":{"direct":false,"nature":"By Squadron Capital LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are held by Squadron Capital LLC (\"Squadron\"). As the President and a member of the Managing Committee of Squadron, the reporting person may be deemed to be the beneficial owner of these shares. The reporting person expressly disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein. The inclusion of these shares in this report shall not be deemed to be an admission of beneficial ownership for purposes of Section 16 or for any other purpose."}],"balance_after":2437092,"source":{"system":"sec-edgar","filing":"0001179110-20-012195","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1350653/000117911020012195/edgar.xml","form_type":"4"}},{"id":3103021,"issuer":{"id":5338,"kind":"organization","name":"ORTHOPEDIATRICS CORP","symbol":"KIDS"},"owners":[{"id":10099,"kind":"person","name":"Pelizzon David R","position":1,"cik":"0001719217","reported_name":"Pelizzon David R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-22T19:22:07.000Z","date":"2020-06-19","kind":"exercise","acquired":false,"shares":1340,"price":30.97,"value":41499.8,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option is fully vested and immediately exercisable."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares of Common Stock and stock option are held by Squadron Capital LLC (\"Squadron\"). As the President and a member of the Managing Committee of Squadron, the reporting person may be deemed to be the beneficial owner of these shares of Common Stock and stock option. The reporting person expressly disclaims beneficial ownership of these shares of Common Stock and stock option, except to the extent of his pecuniary interest therein. The inclusion of these shares of Common Stock and stock option in this report shall not be deemed to be an admission of beneficial ownership for purposes of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"exercise_price":30.97,"expiration_date":"2022-08-23","underlying":"Common Stock","underlying_shares":1340},"source":{"system":"sec-edgar","filing":"0001425450-20-000093","document":"wf-form4_159285370887898.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1425450/000142545020000093/wf-form4_159285370887898.xml","form_type":"4"}},{"id":3103020,"issuer":{"id":5338,"kind":"organization","name":"ORTHOPEDIATRICS CORP","symbol":"KIDS"},"owners":[{"id":10099,"kind":"person","name":"Pelizzon David R","position":1,"cik":"0001719217","reported_name":"Pelizzon David R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-22T19:22:07.000Z","date":"2020-06-19","kind":"exercise","acquired":true,"shares":1340,"price":30.97,"value":41499.8,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are held by Squadron Capital LLC (\"Squadron\"). As the President and a member of the Managing Committee of Squadron, the reporting person may be deemed to be the beneficial owner of these shares. The reporting person expressly disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein. The inclusion of these shares in this report shall not be deemed to be an admission of beneficial ownership for purposes of Section 16 or for any other purpose."}],"balance_after":5376764,"source":{"system":"sec-edgar","filing":"0001425450-20-000093","document":"wf-form4_159285370887898.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425450/000142545020000093/wf-form4_159285370887898.xml","form_type":"4"}},{"id":3104050,"issuer":{"id":4720,"kind":"organization","name":"Alphatec Holdings, Inc.","symbol":"ATEC"},"owners":[{"id":10099,"kind":"person","name":"Pelizzon David R","position":1,"cik":"0001719217","reported_name":"Pelizzon David R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-19T21:08:11.000Z","date":"2020-06-17","kind":"grant","acquired":true,"shares":21142,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On June 17, 2020, issuer granted to the reporting person 21,142 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the 12 month anniversary of the grant date."},{"field":"shares","element":"transactionShares","label":"F1","text":"On June 17, 2020, issuer granted to the reporting person 21,142 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the 12 month anniversary of the grant date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On June 17, 2020, issuer granted to the reporting person 21,142 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the 12 month anniversary of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On June 17, 2020, issuer granted to the reporting person 21,142 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the 12 month anniversary of the grant date."}],"balance_after":137139,"source":{"system":"sec-edgar","filing":"0001179110-20-007647","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1350653/000117911020007647/edgar.xml","form_type":"4"}},{"id":3121980,"issuer":{"id":5338,"kind":"organization","name":"ORTHOPEDIATRICS CORP","symbol":"KIDS"},"owners":[{"id":10099,"kind":"person","name":"Pelizzon David R","position":1,"cik":"0001719217","reported_name":"Pelizzon David R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-04T19:34:32.000Z","date":"2020-06-03","kind":"grant","acquired":true,"shares":1400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes restricted stock awards totaling 2,801 shares."}],"balance_after":17200,"source":{"system":"sec-edgar","filing":"0001425450-20-000077","document":"wf-form4_159129923744914.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425450/000142545020000077/wf-form4_159129923744914.xml","form_type":"4"}},{"id":3497057,"issuer":{"id":5338,"kind":"organization","name":"ORTHOPEDIATRICS CORP","symbol":"KIDS"},"owners":[{"id":10099,"kind":"person","name":"Pelizzon David R","position":1,"cik":"0001719217","reported_name":"Pelizzon David R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-07T19:04:41.000Z","date":"2019-06-05","kind":"grant","acquired":true,"shares":1400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes restricted stock awards totaling 2,334 shares."}],"balance_after":15800,"source":{"system":"sec-edgar","filing":"0001425450-19-000065","document":"wf-form4_155993426688429.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425450/000142545019000065/wf-form4_155993426688429.xml","form_type":"4"}},{"id":3884945,"issuer":{"id":5338,"kind":"organization","name":"ORTHOPEDIATRICS CORP","symbol":"KIDS"},"owners":[{"id":10099,"kind":"person","name":"Pelizzon David R","position":1,"cik":"0001719217","reported_name":"Pelizzon David R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-22T21:01:10.000Z","date":"2018-06-20","kind":"grant","acquired":true,"shares":1400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes restricted stock awards totaling 1,400 shares."}],"balance_after":14400,"source":{"system":"sec-edgar","filing":"0001425450-18-000086","document":"wf-form4_152970125333171.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425450/000142545018000086/wf-form4_152970125333171.xml","form_type":"4"}},{"id":3918515,"issuer":{"id":5338,"kind":"organization","name":"ORTHOPEDIATRICS CORP","symbol":"KIDS"},"owners":[{"id":10099,"kind":"person","name":"Pelizzon David R","position":1,"cik":"0001719217","reported_name":"Pelizzon David R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-24T18:44:04.000Z","date":"2018-05-22","kind":"purchase","acquired":true,"shares":2000,"price":19.5,"value":39000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares purchased by Mr. Pelizzon in the open market."}],"balance_after":13000,"source":{"system":"sec-edgar","filing":"0001425450-18-000072","document":"wf-form4_152718742764554.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425450/000142545018000072/wf-form4_152718742764554.xml","form_type":"4"}},{"id":3998206,"issuer":{"id":5338,"kind":"organization","name":"ORTHOPEDIATRICS CORP","symbol":"KIDS"},"owners":[{"id":10099,"kind":"person","name":"Pelizzon David R","position":1,"cik":"0001719217","reported_name":"Pelizzon David R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-03-13T21:09:20.000Z","date":"2018-03-12","kind":"purchase","acquired":true,"shares":1000,"price":17.5,"value":17500.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares that were purchased by Mr. Pelizzon in the open market."}],"balance_after":11000,"source":{"system":"sec-edgar","filing":"0001425450-18-000037","document":"wf-form4_152097534718300.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425450/000142545018000037/wf-form4_152097534718300.xml","form_type":"4"}},{"id":4185685,"issuer":{"id":5338,"kind":"organization","name":"ORTHOPEDIATRICS CORP","symbol":"KIDS"},"owners":[{"id":10099,"kind":"person","name":"Pelizzon David R","position":1,"cik":"0001719217","reported_name":"Pelizzon David R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B Convertible Preferred Stock","published_at":"2017-10-16T22:07:06.000Z","date":"2017-10-16","kind":"exercise","acquired":false,"shares":4157960,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each share of Series A Convertible Preferred Stock and Series B Convertible Preferred Stock converted into approximately 0.67 shares of Common Stock for no additional consideration immediately prior to the completion of the Issuer's initial public offering. In connection with the conversion of the Series A Convertible Preferred Stock into Common Stock, a $16.00 million preference payment, and approximately $8.96 million of accrued and unpaid dividends, on the Series A Convertible Preferred Stock converted into 1,920,062 shares of Common Stock for no additional consideration at a conversion price of $13.00 per share (the initial public offering price of the Common Stock)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each share of Series A Convertible Preferred Stock and Series B Convertible Preferred Stock converted into approximately 0.67 shares of Common Stock for no additional consideration immediately prior to the completion of the Issuer's initial public offering. In connection with the conversion of the Series A Convertible Preferred Stock into Common Stock, a $16.00 million preference payment, and approximately $8.96 million of accrued and unpaid dividends, on the Series A Convertible Preferred Stock converted into 1,920,062 shares of Common Stock for no additional consideration at a conversion price of $13.00 per share (the initial public offering price of the Common Stock)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each share of Series A Convertible Preferred Stock and Series B Convertible Preferred Stock converted into approximately 0.67 shares of Common Stock for no additional consideration immediately prior to the completion of the Issuer's initial public offering. In connection with the conversion of the Series A Convertible Preferred Stock into Common Stock, a $16.00 million preference payment, and approximately $8.96 million of accrued and unpaid dividends, on the Series A Convertible Preferred Stock converted into 1,920,062 shares of Common Stock for no additional consideration at a conversion price of $13.00 per share (the initial public offering price of the Common Stock)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"These shares are held by Squadron Capital LLC (\"Squadron\"). As the President and a member of the Managing Committee of Squadron, the reporting person may be deemed to be the beneficial owner of these shares. The reporting person expressly disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein. The inclusion of these shares in this report shall not be deemed to be an admission of beneficial ownership for purposes of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2785833},"source":{"system":"sec-edgar","filing":"0001144204-17-052690","document":"tv477023_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1425450/000114420417052690/tv477023_4.xml","form_type":"4"}},{"id":4185684,"issuer":{"id":5338,"kind":"organization","name":"ORTHOPEDIATRICS CORP","symbol":"KIDS"},"owners":[{"id":10099,"kind":"person","name":"Pelizzon David R","position":1,"cik":"0001719217","reported_name":"Pelizzon David R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Convertible Preferred Stock","published_at":"2017-10-16T22:07:06.000Z","date":"2017-10-16","kind":"exercise","acquired":false,"shares":1000000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each share of Series A Convertible Preferred Stock and Series B Convertible Preferred Stock converted into approximately 0.67 shares of Common Stock for no additional consideration immediately prior to the completion of the Issuer's initial public offering. In connection with the conversion of the Series A Convertible Preferred Stock into Common Stock, a $16.00 million preference payment, and approximately $8.96 million of accrued and unpaid dividends, on the Series A Convertible Preferred Stock converted into 1,920,062 shares of Common Stock for no additional consideration at a conversion price of $13.00 per share (the initial public offering price of the Common Stock)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each share of Series A Convertible Preferred Stock and Series B Convertible Preferred Stock converted into approximately 0.67 shares of Common Stock for no additional consideration immediately prior to the completion of the Issuer's initial public offering. In connection with the conversion of the Series A Convertible Preferred Stock into Common Stock, a $16.00 million preference payment, and approximately $8.96 million of accrued and unpaid dividends, on the Series A Convertible Preferred Stock converted into 1,920,062 shares of Common Stock for no additional consideration at a conversion price of $13.00 per share (the initial public offering price of the Common Stock)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each share of Series A Convertible Preferred Stock and Series B Convertible Preferred Stock converted into approximately 0.67 shares of Common Stock for no additional consideration immediately prior to the completion of the Issuer's initial public offering. In connection with the conversion of the Series A Convertible Preferred Stock into Common Stock, a $16.00 million preference payment, and approximately $8.96 million of accrued and unpaid dividends, on the Series A Convertible Preferred Stock converted into 1,920,062 shares of Common Stock for no additional consideration at a conversion price of $13.00 per share (the initial public offering price of the Common Stock)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"These shares are held by Squadron Capital LLC (\"Squadron\"). As the President and a member of the Managing Committee of Squadron, the reporting person may be deemed to be the beneficial owner of these shares. The reporting person expressly disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein. The inclusion of these shares in this report shall not be deemed to be an admission of beneficial ownership for purposes of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":670000},"source":{"system":"sec-edgar","filing":"0001144204-17-052690","document":"tv477023_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1425450/000114420417052690/tv477023_4.xml","form_type":"4"}},{"id":4185683,"issuer":{"id":5338,"kind":"organization","name":"ORTHOPEDIATRICS CORP","symbol":"KIDS"},"owners":[{"id":10099,"kind":"person","name":"Pelizzon David R","position":1,"cik":"0001719217","reported_name":"Pelizzon David R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-10-16T22:07:06.000Z","date":"2017-10-16","kind":"purchase","acquired":true,"shares":10000,"price":13,"value":130000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares that were purchased through a directed share program in connection with the Issuer's initial public offering."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001144204-17-052690","document":"tv477023_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1425450/000114420417052690/tv477023_4.xml","form_type":"4"}},{"id":4185682,"issuer":{"id":5338,"kind":"organization","name":"ORTHOPEDIATRICS CORP","symbol":"KIDS"},"owners":[{"id":10099,"kind":"person","name":"Pelizzon David R","position":1,"cik":"0001719217","reported_name":"Pelizzon David R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-10-16T22:07:06.000Z","date":"2017-10-16","kind":"exercise","acquired":true,"shares":1920062,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares received upon conversion of a $16.0 million preference payment, and approximately $8.96 million of accrued and unpaid dividends, on the Series A Convertible Preferred Stock immediately prior to the completion of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each share of Series A Convertible Preferred Stock and Series B Convertible Preferred Stock converted into approximately 0.67 shares of Common Stock for no additional consideration immediately prior to the completion of the Issuer's initial public offering. In connection with the conversion of the Series A Convertible Preferred Stock into Common Stock, a $16.00 million preference payment, and approximately $8.96 million of accrued and unpaid dividends, on the Series A Convertible Preferred Stock converted into 1,920,062 shares of Common Stock for no additional consideration at a conversion price of $13.00 per share (the initial public offering price of the Common Stock)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"These shares are held by Squadron Capital LLC (\"Squadron\"). As the President and a member of the Managing Committee of Squadron, the reporting person may be deemed to be the beneficial owner of these shares. The reporting person expressly disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein. The inclusion of these shares in this report shall not be deemed to be an admission of beneficial ownership for purposes of Section 16 or for any other purpose."}],"balance_after":5378441,"source":{"system":"sec-edgar","filing":"0001144204-17-052690","document":"tv477023_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1425450/000114420417052690/tv477023_4.xml","form_type":"4"}},{"id":4185681,"issuer":{"id":5338,"kind":"organization","name":"ORTHOPEDIATRICS CORP","symbol":"KIDS"},"owners":[{"id":10099,"kind":"person","name":"Pelizzon David R","position":1,"cik":"0001719217","reported_name":"Pelizzon David R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-10-16T22:07:06.000Z","date":"2017-10-16","kind":"exercise","acquired":true,"shares":3455833,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares received upon conversion of the Series A Convertible Preferred Stock and the Series B Convertible Preferred Stock immediately prior to the completion of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each share of Series A Convertible Preferred Stock and Series B Convertible Preferred Stock converted into approximately 0.67 shares of Common Stock for no additional consideration immediately prior to the completion of the Issuer's initial public offering. In connection with the conversion of the Series A Convertible Preferred Stock into Common Stock, a $16.00 million preference payment, and approximately $8.96 million of accrued and unpaid dividends, on the Series A Convertible Preferred Stock converted into 1,920,062 shares of Common Stock for no additional consideration at a conversion price of $13.00 per share (the initial public offering price of the Common Stock)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"These shares are held by Squadron Capital LLC (\"Squadron\"). As the President and a member of the Managing Committee of Squadron, the reporting person may be deemed to be the beneficial owner of these shares. The reporting person expressly disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein. The inclusion of these shares in this report shall not be deemed to be an admission of beneficial ownership for purposes of Section 16 or for any other purpose."}],"balance_after":3458379,"source":{"system":"sec-edgar","filing":"0001144204-17-052690","document":"tv477023_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425450/000114420417052690/tv477023_4.xml","form_type":"4"}}]}